Remission of localized cutaneous leishmaniasis in a hiv-positive patient using systemic terbinafine

Dermatology

Volumn 194, Issue 1, 1997, Pages 85-86

  Gonzalez Ruperez J ^a   De Morlius, M Javaloyas ^a   Carazo, A Moreno ^b  

^a Hospital Viladecans   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Human immunodeficiency virus; Leishmaniasis; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

EID: 0031025706     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246067     Document Type: Article

References (4)

1. Kolde G. Luger T, Sorg C. Sunderkotter C: Successful treatment of cutaneous leishmaniasis using systemic interferon-gamma. Dermatology 1996; 192:56-60.
2. Pearson RD, de Queiroz Sousa A: Lcishmania species: Visceral (kala-azar), cutaneous and mucosal leishmaniasis; in Mandcll GL, Douglas RG. Bennet JE (eds): Principles and Practice of Infectious Diseases. New York, Churchill Livingstone, 1990. pp 2066-2077.
3. Balfour JA. Faulds D: Terbinafine. Drugs 1992:43:259-284.
4. Vannicr-Santos MA. Urbina JA. Martiny A. Neves A, de Souza W: Alterations induced by the antifungal compounds kétoconazole and terbinafine in Lcishmania. J Eukaryot Microbiol 1995:42:337-346